Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detection by Circulating RNA With Optimized Machine Learning Technology for Breast Cancer: DROPLET-BC Study

NCT04671498 is registered in ClinicalTrials.gov with Preferred Medicine, Inc as lead sponsor.

NCT NCT04671498
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04671498 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detection by Circulating RNA With Optimized Machine Learning Technology for Breast Cancer: DROPLET-BC Study
Lead sponsor
Preferred Medicine, Inc
Phase
Observational
Overall status
Unknown status
Start date
November 3, 2020
Completion date
December 31, 2022
Enrollment
1,200 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast carcinoma